Aurion Biotech
Entity

  • Aurion Biotech

    Created in 2021
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    4,313

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Bainbridge Island, WA 98110, USA

    Bainbridge Island

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 72

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    7 months, 2 weeks ago
Description
  • Value proposition

    We're on a mission to cure blindness with our transformational platform of advanced therapies

    Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

  • Advanced Therapies for Ocular Diseases - Aurion Biotech

    We are a clinical-stage biotech company that aims to restore vision by developing a platform of innovative, accessible, and effective advanced therapies.

    • https://aurionbiotech.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration 		Other

7 Nov 2022


Similar entities
Last news
Show all articles
Social network dynamics